KEY FEATURES
| Full Name | Cyclin D1 |
|---|---|
| Synonym | CCN-D1; BCL1; PRAD1; U21B31; G1/S-Specific Cyclin-D1; Parathyroid Adenomatosis 1; B-Cell CLL/Lymphoma 1; G1/S-Specific Cyclin D1; PRAD1 oncogene |
| Assay Type | Sandwich |
| Reactivity | Mouse |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Mouse CCND1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Mouse CCND1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Mouse CCND1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Mouse CCND1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Mouse CCND1. You can calculate the concentration of Mouse CCND1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES
TYPICAL DATA
Mouse CCND1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.47 | 1.11 | 4.43 | 0.44 | 1.08 | 4.19 |
| Standard deviation | 0.03 | 0.05 | 0.18 | 0.03 | 0.06 | 0.15 |
| CV(%) | 6.97 | 4.6 | 4.03 | 6.89 | 5.97 | 3.61 |
RECOVERY
The recovery of Mouse CCND1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 90-104 | 95 |
| EDTA plasma (n=8) | 86-100 | 93 |
| Cell culture media (n=8) | 89-101 | 95 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Mouse CCND1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.
Products associated with CD ELISA Kits
| CDK4 ELISA Kit | publications with CD and CDK4 |
| CDKN1A ELISA Kit | publications with CD and CDKN1A |
| CDK2 ELISA Kit | publications with CD and CDK2 |
| CDKN1B ELISA Kit | publications with CD and CDKN1B |
| PCNA ELISA Kit | publications with CD and PCNA |
| CDK6 ELISA Kit | publications with CD and CDK6 |
| STAT3 ELISA Kit | publications with CD and STAT3 |
| RB1 ELISA Kit | publications with CD and RB1 |
| ESR1 ELISA Kit | publications with CD and ESR1 |
| UBC ELISA Kit | publications with CD and UBC |
Pathways associated with CD ELISA Kit
| AMPK Signaling Pathway | AMPK Signaling Pathway |
| ATF-2 Transcription Factor Network Pathway | ATF-2 Transcription Factor Network Pathway |
| Acute Myeloid Leukemia Pathway | Acute Myeloid Leukemia Pathway |
| Androgen Receptor Signaling Pathway | Androgen Receptor Signaling Pathway |
| Bladder Cancer Pathway | Bladder Cancer Pathway |
| C-MYB Transcription Factor Network Pathway | C-MYB Transcription Factor Network Pathway |
| Cell Cycle Pathway | Cell Cycle Pathway |
Diseases associated with CD ELISA Kit
| Carcinoma | publications with CD and Carcinoma |
| Breast Neoplasms | publications with CD and Breast Neoplasms |
| Neoplasms, Experimental | publications with CD and Neoplasms, Experimental |
| Cell Transformation, Neoplastic | publications with CD and Cell Transformation, Neoplastic |
| Colorectal Neoplasms | publications with CD and Colorectal Neoplasms |
| Leukemia | publications with CD and Leukemia |
| Liver Diseases | publications with CD and Liver Diseases |
| Lung Neoplasms | publications with CD and Lung Neoplasms |
| Liver Neoplasms | publications with CD and Liver Neoplasms |
| Carcinoma, Hepatocellular | publications with CD and Carcinoma, Hepatocellular |
Organs/Tissues associated with CD ELISA Kit
| Blood | publications with CD and Blood |
| Liver | publications with CD and Liver |
| Vascular | publications with CD and Vascular |
| Lung | publications with CD and Lung |
| Muscle | publications with CD and Muscle |
| Bone | publications with CD and Bone |
| Brain | publications with CD and Brain |
| Lymph Node | publications with CD and Lymph Node |
| Lymph | publications with CD and Lymph |
| Prostate | publications with CD and Prostate |
